Research Article
Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer
Table 3
Comparison of clinical characteristics between the training and testing sets.
| | Characteristics | Training set | Testing set | value | | Number (%) or | Number (%) or |
| | Sex | | | 0.349 | | Male | 191 (77.0%) | 182 (73.4%) | | | Female | 57 (23.0%) | 66 (26.6%) | | | Age (year) | | | 0.442 | | Stage | | | 0.056 | | I | 49 (19.8%) | 38 (15.3%) | | | II | 80 (32.3%) | 66 (26.6%) | | | III | 76 (30.6%) | 105 (42.3%) | | | IV | 43 (17.3%) | 39 (15.7%) | | | Adjuvant chemotherapy | | | 0.288 | | Yes | 118 (47.6%) | 107 (43.1%) | | | No | 40 (16.1%) | 34 (13.7%) | | | Unknown | 90 (36.3%) | 107 (43.1%) | | | Death | | | 0.578 | | Yes | 152 (61.3%) | 158 (63.7%) | | | No | 96 (38.7%) | 90 (36.3%) | | | Recurrence | | | 0.063 | | Yes | 95 (38.3%) | 81 (32.7%) | | | No | 135 (54.4%) | 134 (54.0%) | | | Unknown | 18 (7.3%) | 33 (13.3%) | | | GEO database | | | 0.241 | | GSE26901 | 46 (18.5%) | 36 (14.5%) | | | GSE26899 | 28 (11.3%) | 31 (12.5%) | | | GSE66229 | 72 (29.0%) | 74 (29.8%) | | | GSE26253 | 75 (30.2%) | 64 (25.8%) | | | GSE29272 | 18 (7.3%) | 33 (13.3%) | | | GSE13861 | 9 (3.6%) | 10 (4%) | |
|
|
